Point72 Europe (London) LLP Boston Scientific Corp Transaction History

Point72 Europe (London) LLP

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$48.64 - $57.81 $8.08 Million - $9.6 Million
-166,126 Reduced 54.33%
139,667 $8.07 Million
Q3 2023

Nov 14, 2023
BUY
$50.19 - $54.68 $13 Million - $14.2 Million
258,880 Added 551.83%
305,793 $16.1 Million
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $2.33 Million - $2.56 Million
46,913 New
46,913 $2.54 Million

Others Institutions Holding BSX

# of Institutions
1,596
Shares Held
1.19B
Call Options Held
6.83M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $151B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email